Ureterolithiasis
13
0
0
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
15.4%
2 terminated out of 13 trials
66.7%
-19.8% vs benchmark
31%
4 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (13)
Super-Pulsed Thulium Fiber Laser Versus Holmium:YAG Laser in Retrograde Intrarenal Surgery for Upper Ureteral and Renal Stones
An Intelligent Pressure and Temperature Control Ureteral Soft Scope System for Treating Stones With Infection.
PRedictive Accuracy of Initial Stone Burden Evaluation.
Comparison of Lithotripsy Urolithiasis Machines
US-Non Contrast Computed Tomography Real-time Fusion for Urinary Stones Follow up
Effect of Furosemide on ESWL Outcomes for Renal and Ureteral Calculi
Ureteroscopic Lithotripsy in the Reverse Trendelenburg Position for Upper Ureteral Stones
Silodosin Versus Tamsulosin for Treatment of Ureteral Stones
Tamsulosin as Adjuvant Treatment Prior to Endoscopic Ureterolithotomy
Sterile Water Injections for Relieving Ureterolithiasis Pain
Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During Ureteroscopy
Evaluation of Tamsulosin in the Treatment of Ureteral Stones
Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy